SafetyCraft Drop-Side Crib Hardware Linked to Deaths, CPSC Warns

Generation 2 Worldwide “SafetyCraft” drop-side cribs contain parts that are identical to those used in other cribs that were recalled after being linked to infant deaths and injuries, product safety officials are warning. 

The U.S. Consumer Product Safety Commission (CPSC) issued a warning to users of the SafetyCraft drop-side cribs, indicating that they have parts that appear to be the same as those used in cribs recalled a year ago after at least three infants died in the cribs and 20 more were injured.

It was determined that the hardware on the cribs may break, causing the drop side to detach and potentially entrap and suffocate infants.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The manufacturer, Generation 2 Worldwide, went out of business in 2005. The “SafetyCraft” trademark was bought by Foundations Children’s Products of Medina, Ohio, but those cribs are not affected by this warning.

The CPSC warns that because Generation 2 Worldwide no longer exists, there is limited information on the cribs or where they were sold. However, they all have the name “SafetyCraft” on a label affixed to the headboard or footboard, and will be labeled as made in either Indonesia or Dothan, Alabama. The warning applies to all SafetyCraft cribs made by Generation 2 Worldwide.

The recall comes about five months before a drop-side crib ban enacted by the CPSC goes into effect in June. The commission voted in December to ban all drop side cribs from the market, including the sale, resale and manufacture of the cribs. The vote came after the drop-side crib design has been linked to 32 infant and toddler deaths since 2000, and are suspected in 14 other fatalities.

Drop-side crib safety issues have resulted in millions of cribs being recalled in recent years. The cribs are designed to allow easy access to the baby by having one side that can be unlocked and lowered. They have been particularly popular with shorter parents or those with back problems who have difficulty reaching over the rails of a standard crib.

Problems with the designs of many drop-side cribs have allowed the moving parts to become loose or fall out, creating a gap that can trap or suffocate the infant. Problems with drop side cribs have involved malfunctioning retractable pegs, metal locking pins that came loose, broken slats and other issues.

Many major retailers previously agreed to stop selling drop side cribs, and a number of drop side crib lawsuits have been filed against both manufacturers and retailers who sold defective cribs.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.